CONMED Corp — Director's Dealing 2017

Mar 7, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2017-03-06

Reporting Person: TRYNISKI MARK E (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-06	Common Stock	P	5000	$41.15	Acquired	27000	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $41.10 to $41.25, inclusive. Full information regarding the number of shares purchased at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.